Skip to main content
. 2021 Dec 21;2021(12):CD013139. doi: 10.1002/14651858.CD013139.pub2

Noordzij 2006.

Study characteristics
General information Objective 
  • Added biomarkers     


Journal
  • American Journal of Cardiology


Country
  • The Netherlands


Study design
  • Retrospective cohort study

Participants Number of included patients
  • 28,457


Surgical specialty
  • Noncardiac surgery


Age
  • Median 60.1 years (IQR = 49.1 to 71.2 years)


Male sex
  • Not reported


High‐risk surgery
  • 43.4%  


Insulin‐dependent diabetes mellitus
  • Not reported 


History of ischaemic heart disease
  • 2.7%


History of congestive heart failure
  • 0.6%


History of cerebrovascular events
  • Not reported 


Elevated creatinine
  • 0.6%


0 RCRI factors
  • 95%


1 RCRI factor
  • 4.3%


2 RCRI factors
  • 0.6%


3 of more RCRI factors
  • 0.1%

Predictors Predictor 1:
ECG abnormalities  
  • Objective: added biomarkers 

  • Category: imaging

  • Scale: dichotomous

  • Threshold: not applicable

  • Assay/device: not applicable


 
Predictor 2:
Age   
  • Objective: added biomarker 

  • Category: patient characteristic

  • Scale: not reported

  • Threshold: not applicable

  • Assay/device: not applicable

Outcome Outcome category
  • Cardiovascular death


Full outcome definition
  • Not applicable


Prediction horizon
  • 30‐day events

Analysis Number of outcomes
  • 199


Handling missing data
  • No information on handling missing data


Discrimination reported?
  • Yes


Calibration reported?
  • No  


Reclassification reported?
  • No

PROBAST: Applicability Domain 1: Participant selection
  • High


Justification: only patients at high risk for CAD included
Domain 2: Predictors
  • High


Justification: predictor definitions very different from the development study
Domain 3: Outcome
  • High


Justification: outcome was cardiovascular death and not MACE
Overall judgement
  • High


Justification: only a selected group of patients was included; predictors of the original RCRI were not included or had a different definition. In addition, the outcome definition used was different compared to the development study.
Notes
 
Item Authors' judgement Support for judgement
Domain 1: Participant selection Yes Appropriate participant selection in which patients were selected in whom the RCRI model can be applied.
Domain 2: Predictors No Predictor definitions very different from the development study.
Domain 3: Outcome Yes Clearly defined outcome definitions and appropriate adjudication of outcomes.
Domain 4:  Analysis No No information on handling of missing data and calibration/reclassification not assessed.
Overall judgement No Patient selection was appropriate and outcomes was clearly defined and assessed. Predictor definitions were defined differently compared to the definitions used in the RCRI development study. Furthermore, there was no information on handling of missing data and inappropriate reporting of performance measures.